S&P 500   4,574.79 (+0.18%)
DOW   35,756.88 (+0.04%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
S&P 500   4,574.79 (+0.18%)
DOW   35,756.88 (+0.04%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
S&P 500   4,574.79 (+0.18%)
DOW   35,756.88 (+0.04%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
S&P 500   4,574.79 (+0.18%)
DOW   35,756.88 (+0.04%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
NYSE:CRL

Charles River Laboratories International News Headlines

$429.83
+6.01 (+1.42 %)
(As of 10/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$423.09
$431.45
50-Day Range
$398.46
$458.30
52-Week Range
$219.79
$460.21
Volume257,641 shs
Average Volume412,803 shs
Market Capitalization$21.66 billion
P/E Ratio55.39
Dividend YieldN/A
Beta1.14

Media Mentions By Week



Charles River Laboratories International Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRL
News Sentiment

-0.49

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRL Articles
This Week

5

1

CRL Articles
Average Week

Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

Charles River Laboratories International (NYSE CRL) News Headlines Today

SourceHeadline
MarketBeat logoContrasting CM Life Sciences II (NASDAQ:CMII) & Charles River Laboratories International (NYSE:CRL)
americanbankingnews.com - October 22 at 5:04 AM
MarketBeat logoResearch Analysts Issue Forecasts for Charles River Laboratories International, Inc.'s FY2021 Earnings (NYSE:CRL)
americanbankingnews.com - October 18 at 1:46 AM
MarketBeat logoCharles River Laboratories International (NYSE:CRL) Receives Buy Rating from Evercore ISI
americanbankingnews.com - October 14 at 8:08 AM
finance.yahoo.com logoCharles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
finance.yahoo.com - October 13 at 5:34 PM
finance.yahoo.com logoHedge Funds Keep Buying Charles River Laboratories International Inc. (CRL)
finance.yahoo.com - October 4 at 1:01 PM
finance.yahoo.com logoHere’s What Makes Charles River Laboratories (CRL) A Great Investment
finance.yahoo.com - October 1 at 1:59 PM
nasdaq.com logoCharles River Laboratories International Inc. Shares Approach 52-Week High - Market Mover
nasdaq.com - September 23 at 4:53 AM
finance.yahoo.com logoWhy Is Charles River (CRL) Up 9.5% Since Last Earnings Report?
finance.yahoo.com - September 3 at 6:15 PM
nasdaq.com logoCharles River Laboratories International Reaches Analyst Target Price
nasdaq.com - August 20 at 9:22 PM
finance.yahoo.com logoA surprising key to making sure vaccines — including for COVID-19 — are safe? The blue blood of horseshoe crabs
finance.yahoo.com - August 20 at 4:21 PM
nasdaq.com logoHave Insiders Sold Charles River Laboratories International, Inc. (NYSE:CRL) Shares Recently?
nasdaq.com - August 11 at 8:01 AM
fool.com logoCharles River Laboratories International, inc (CRL) Q2 2021 Earnings Call Transcript
fool.com - August 4 at 5:07 PM
finance.yahoo.com logoCharles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
finance.yahoo.com - August 4 at 1:32 PM
finance.yahoo.com logoCharles River (CRL) Q2 Earnings Beat Estimates, 2021 View Up
finance.yahoo.com - August 4 at 1:32 PM
markets.businessinsider.com logoCharles River Labs Boosts FY21 Outlook As Q2 Results Top Estimates - Quick Facts
markets.businessinsider.com - August 4 at 8:32 AM
finance.yahoo.com logoCharles River Laboratories Announces Second-Quarter 2021 Results
finance.yahoo.com - August 4 at 8:32 AM
finance.yahoo.com logoCharles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
finance.yahoo.com - July 13 at 12:41 PM
finance.yahoo.com logoCharles River (CRL) at a 52-Week High: What's Driving It?
finance.yahoo.com - July 13 at 12:41 PM
nasdaq.com logoWhat's Next For Charles River Laboratories Stock After A 13% Rise Last Month?
nasdaq.com - July 8 at 4:36 AM
finance.yahoo.com logoCharles River (CRL) Advances in Gene Therapy With Vigene Buyout
finance.yahoo.com - June 30 at 1:25 PM
finance.yahoo.com logoCharles River Laboratories Completes Acquisition of Vigene Biosciences
finance.yahoo.com - June 29 at 7:21 AM
finance.yahoo.com logoWhat Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
finance.yahoo.com - June 22 at 12:51 PM
finance.yahoo.com logoCharles River Laboratories International, Inc. (CRL)
finance.yahoo.com - June 18 at 12:58 AM
nasdaq.com logoThere's Reason For Concern Over Charles River Laboratories International, Inc.'s (NYSE:CRL) Price
nasdaq.com - May 31 at 5:14 PM
finance.yahoo.com logoIs It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
finance.yahoo.com - May 7 at 9:09 AM
finance.yahoo.com logoCharles River Laboratories International, Inc.: Charles River Reports Strong Q1 Results and Momentum for a Healthy 2021; Raising FVE to $170
finance.yahoo.com - May 7 at 4:08 AM
seekingalpha.com logoCharles River Laboratories International, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 6 at 10:24 AM
finance.yahoo.com logoCharles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 4 at 5:15 PM
finance.yahoo.com logoCharles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
finance.yahoo.com - May 4 at 12:15 PM
finance.yahoo.com logoCharles River Laboratories Announces First-Quarter 2021 Results
finance.yahoo.com - May 4 at 7:14 AM
finance.yahoo.com logoThree Medical Leaders To Watch, Including One With A Potential Breakout
finance.yahoo.com - April 22 at 6:40 PM
finance.yahoo.com logoCharles River Labs International Shows Rising Relative Strength
finance.yahoo.com - April 16 at 1:30 PM
finance.yahoo.com logoCharles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
finance.yahoo.com - April 13 at 8:47 AM
finance.yahoo.com logoCharles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
finance.yahoo.com - April 6 at 9:02 AM
finance.yahoo.com logoCharles River Laboratories Acquires Retrogenix
finance.yahoo.com - March 31 at 9:40 AM
finance.yahoo.com logoCharles River Laboratories Completes the Acquisition of Cognate BioServices
finance.yahoo.com - March 29 at 5:32 PM
finance.yahoo.com logoIs CRL Stock A Buy or Sell?
finance.yahoo.com - March 29 at 5:32 PM
finance.yahoo.com logoCharles River Laboratories Announces Closing of Senior Notes Offering
finance.yahoo.com - March 23 at 6:05 PM
finance.yahoo.com logoCharles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
finance.yahoo.com - March 8 at 12:33 PM
finance.yahoo.com logoCharles River Laboratories Int'l, Inc. -- Moody's assigns Ba2 ratings to Charles River's new senior unsecured notes
finance.yahoo.com - March 8 at 12:33 PM
finance.yahoo.com logoCharles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
finance.yahoo.com - February 25 at 9:30 AM
finance.yahoo.com logoLook for the Rally in Charles River Labs to Continue
finance.yahoo.com - February 24 at 12:42 PM
benzinga.com logoCharles River: Q4 Earnings Insights
benzinga.com - February 17 at 8:35 AM
nasdaq.com logoCharles River Q4 Profit Tops Estimates; To Acquire Cognate BioServices
nasdaq.com - February 17 at 8:35 AM
finance.yahoo.com logoWhy Charles River (CRL) Could Beat Earnings Estimates Again
finance.yahoo.com - January 29 at 2:05 PM
finance.yahoo.com logoCharles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening
finance.yahoo.com - January 28 at 12:14 PM
finance.yahoo.com logoCharles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
finance.yahoo.com - January 20 at 10:23 AM
finance.yahoo.com logoCharles River Partners with JADE Biomedical to Expand Biologics Capabilities
finance.yahoo.com - January 14 at 6:05 PM
finance.yahoo.com logoCharles River Laboratories Acquires Distributed Bio
finance.yahoo.com - January 4 at 8:40 AM
finance.yahoo.com logoIs Charles River Laboratories (CRL) a Smart Long-term Buy?
finance.yahoo.com - December 16 at 12:52 PM
Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.